AC Immune (ACIU) Other financing activities (2017 - 2018)

AC Immune (ACIU) has reported Other financing activities for 11 consecutive years, with $205018.0 the latest figure, recorded in Q3 2025.

• In Q3 2025, Other financing activities rose 105.65% year-over-year to $205018.0; the TTM figure through Sep 2025 stood at -$3.7 million (down 215.17% YoY), while the FY2016 annual figure was $18.3 million, down 36.79% from the prior year.
• Other financing activities slipped to $205018.0 in Q3 2025 per ACIU's latest filing, from $478267.7 in the prior quarter.
• Across five years, Other financing activities topped out at $8.5 million in Q1 2021 and bottomed at -$8.1 million in Q2 2022.
• Historically, Other financing activities has averaged $763391.5 across 5 years, with a median of -$20836.3 in 2021.
• Annual changes were most pronounced in 2021 — Other financing activities surged 3291.21% — and 2022, when it tumbled 38892.74%.
• AC Immune's Other financing activities stood at $5.1 million in 2021, then jumped by 53.69% to $7.8 million in 2022, then tumbled by 101.95% to -$152443.9 in 2023, then sank by 2281.19% to -$3.6 million in 2024, then jumped by 105.65% to $205018.0 in 2025.
• Business Quant data shows ACIU's Other financing activities at $205018.0 in Q3 2025, $478267.7 in Q1 2025, and -$3.6 million in Q3 2024.